Sivik Global Healthcare LLC / VRTX
Sivik Global Healthcare LLC’s Vertex Pharmaceuticals Inc Position
Does Sivik Global Healthcare LLC own Vertex Pharmaceuticals Inc (VRTX)? Yes — 10.0K shares worth $4M (+3.39% of its 13F portfolio) as of Q1 2026, down from 13.8K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
10.0K
% of Portfolio
+3.39%
Quarters Held
20
currently held
Position History VRTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 10.0K | $4M | +3.39% |
| Q4 2025 | 13.8K | $6M | +1.81% |
| Q3 2025 | 14.0K | $5M | +1.60% |
| Q4 2024 | 13.0K | $5M | +2.76% |
| Q3 2024 | 10.0K | $5M | +1.97% |
| Q2 2024 | 15.0K | $7M | +2.53% |
| Q1 2024 | 11.0K | $5M | +1.08% |
| Q4 2023 | 12.5K | $5M | +2.12% |
| Q3 2023 | 12.5K | $4M | +2.19% |
| Q2 2023 | 14.0K | $5M | +1.15% |
| Q1 2023 | 15.0K | $5M | +2.03% |
| Q4 2022 | 15.0K | $4M | +2.04% |
| Q1 2021 | 15.0K | $3M | +1.18% |
| Q2 2020 | 30.0K | $6M | +1.86% |
| Q1 2020 | 25.0K | $4M | +1.75% |
| Q4 2019 | 32.5K | $7M | +2.64% |
| Q3 2019 | 40.0K | $7M | +3.42% |
| Q2 2019 | 30.0K | $6M | +1.33% |
| Q1 2019 | 30.0K | $6M | +2.03% |
| Q4 2018 | 35.0K | $6M | +3.13% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sivik Global Healthcare LLC’s full portfolio or all institutional holders of VRTX.